clinical use, sera- and animal-free media are being developed. We therefore formulated a human platelet lysate-based, serum-free media, MSC ExHQ Cell RevTM media that can be used
detected robust mineralization of Jaw Periosteal Cells (JPCs) under cultivation with clinical approved Human Platelet Lysate (hPL) compared to FCS conditions. In the present study, we performed qualitative analyses
expanded according to GMP procedures, using a cell growth medium supplemented with pooled human platelet lysate, which provided a significantly higher proliferation rate compared to FBS. Before release, cells were
niche. We recently observed an elevated expression of CD146 on human bmMSCs upon expansion in medium enriched with platelet lysate. We therefore investigated if CD146 expression followed comparable paths ... human…
hydroxyapatite with Advanced Platelet Rich Fibrin (A-PRF) and Hydroxyapatite reinforced Beta Tri-Calcium Phosphate (HA+β-TCP) with A-PRF in the treatment of human infrabony defects clinically
however, this process is often incomplete because of fibrotic tissue formation. Growth factors from platelet-rich plasma (PRP) with proven effects in tendinous and ligamentous healing have not yet been ... combination…
variants (bioscavengers) and used as therapeutics. Some enzymes associated with lipoproteins, such as human plasma platelet-activating factor acetylhydrolase (pPAF-AH), are also inhibited by OPs; these proteins have…
Platelet lysate (PL) is obtained from human blood platelets after freeze/thaw cycle in order to obtain a large quantity of growth factor (GF) necessary for cell culture ... quality for all therapy and regenerative…
with platelet agonists and probiotic lactic acid bacteria strains. Platelet activation was determined by labelling with FITC-conjugated anti-human fibrinogen and phycoerythrin (PE)- conjugated anti-human CD62p before…
JAK2 and STAT signaling pathways and stimulates isolated human CD34+ (stem/primitive progenitor) cells to become megakaryocytes and produce platelets. Th e drug interacts with the transmembrane (TM) domain ... diff…
individually, better than fluconazole. In vitro poisonousness profiling uncovered non-hemolytic movement against human red platelets (hRBC) yet halfway cytotoxicity to human early stage kidney cells (HEK293). Also, in…
alpha, to better recreate the composition of the vascular niche. After staining, human umbilical cord blood derived megakaryocytes were added to hydrogel and megakaryocytes migration was analyzed in a time ... platelets…
Trimeresurus albolabris), GPV-TL1, in Pichia pastoris system and characterized its activities on human fibrinogen and platelets. The recombinant protein migrates as an approximately 31.6 kDa on SDS-PAGE under…
utilized in this review, either human serum, human serum in addition to platelet lysate (PLL), or human plasma in addition to PLL was utilized. We report that improvement of media
Pristine and engineered nano-materials are administered in human body or other bio-systems (a test model) either directly or via release form the pharmaceutical products, implants, and the products ... these…
provides proper scaffolding to the newly formed plug The normal range of platelet count in adult human is somewhere between 150x10*9/L and 450x10*9/L. Platelet abnormalities encompass
influence their fate. Human bone marrow (BM) or umbilical cord (UC) MSC adhered from flow to matrix proteins. However, they displayed distinct interactions with platelets when perfused in whole blood ... this could be…
influence their fate. Human bone marrow (BM) or umbilical cord (UC) MSC adhered from flow to matrix proteins. However, they displayed distinct interactions with platelets when perfused in whole blood ... this could be…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.